Yahoo Finanza Italia rimuoverà le nostre bacheche con le conversazioni il giorno 15 agosto. Grazie per essere un membro così fedele della nostra community di conversazioni di finanza!
$ARKK down 2% on another huge green day for the market. Imagine how hard it will drop when markets pull back again.
E
$ROKU $ARKK so she buys Roku 3 days ago - 500,000 shares.. it goes down 27% from that point and she doesn’t buy?? She is the strangest person I ever saw….
Hello Legends, >> MEGL << Float is getting Tight ! --- About to be Our Day. Doesn't take much to make PPS move UP now. Shawts are worried. Capture Soldiers. --- * J The Legend !
Value vs Fast growing tech: ARK ETFS are not dotcoms. Jay Dilks @DilksJay I’ve sort of noticed some “Value” Managers that have been critics of $ARKK & @CathieDWood have been unusually quite as a reckoning has come to their Funds in the form of outflows & underperformance. They tried to seduce you w/ safety and all they have delivered is false promises 11:19 AM · Jul 24, 2022 What comes next for them is deflection and pointing to brief outperformance a year ago while trying to misdirect underperformance for the past 10-20 years. I’m not one to name names, but they know who they are. Investing is humbling enough without attacking other Managers.
At the time of someone else’s choosing, they’ve put together a compilation of Tweets over the last year of popular Twitter Personalities and Managers of what their top picks were at the time. Some of these picks have been quite awful in 2022. If they manage money, they’ve lost.
All Legends, Lotto Play here>> MEGL << Up (+2,325.00%) At close: 04:00PM Friday, August 5, 2022. It's up $32 dollars Extended Hours. --- * J The Legend !
All the $arkk $ should check out the Frightened short lowlife at $L$ DD 2,500% + ROI Potential Gps' Lead investigator, the Chair of MD Andersons Leukemia Dept, sees open label p3 trial data, and has requested Expanded Access for additional AML patients, - basically confirming Gps is doing what it has done in all previous trials, including the Moffitt Center P2, where Gps patients survived an average of 21 months compared to only 5.4 with the best available treatments. Control Patients in the phase 3 are on the same one of 4 treatments used in the P2. There have been no new therapies, since.
$ARKK $ARKF one of the biggest turn offs to me about ARK was their obsession with crypto and $COIN. It's why I would never buy ARK etfs again. I guess COIN is going to drag ARK down even more on Monday. Bitcoin is taking yet another bath.
$ARKK I hear Cathie Wood loaded a ton more cheaper and cheaper cheapies of da cheap $COIN $HOOD $UPST $TDOC she's a real wiz but oddly not on TV anymore?
h
This will go down harder then it came up $ARKK $QQQ $TSLA $COIN
做好準備嘅朋友,它在市場開放時掌握喺你嘅手中。 多谢你,* J傳奇!
$AMTD $HKD $FAZE $SYM $KPLT $ISEE $DARE $ENVB $UWMC $ANY $DVAX $EXPR $KPTI $CHS $AIKI $AEI $APRN $EVGO $PHUN $HYLN $ MVIS $GOEV $MNMD $ROOT $MKD $BTBT $MMAT $NAK $AUPH $NNDM $SDC $GSAT $STEM $RDBX $IDEX $WE $DBGI $BNGO $BKKT $BB $OCGN $CLOV $ATER
$AEX $ARKK $AAL $AMC $AMD $AAPL $AMZN $APRN $ATER
$BBBY $BABA $BBI $BWV $BMEA $BBIG $BEAT $CCL $CEI
$ERIC $RIDE $SPCE $SKLZ $CSCW $FSR $GRAB $WISH $CLF $DIDI $FUBO $OPEN $BRQS $CYN $CEI $YLRY $FAMI $NOK $LCID $VALE $MULN $BBIG $SNDL $RIVN $CFVI $DWAC
$DAL $DKNG $GME $GLD $GLE $HOOD $HYMC $ITP $ING $IGEX
$JBLU $LCID $LUV $MULN $META $MULN $NCLH $NDX $PVSP
$QQQ $RCL $RDBX $SAVE $STRN $STEM $SPY $SAVE $SPX $SOFI $SNOA $TWTR $TKAT $TSLA $UAL $VERU $XRTX $XCUR $CENN $AEI $LYFT $JWN $DKS $WEN $INTU $NERO $WEJO $TTOO $VYNE $SIOX $ALNA $ROKU $ARKK $COMP $BHLB $ADER $OCGN $ALZN $ADTX $PLTR, $RKT $SOFI $SNDL $AGRX $DPLS $ADN $RIGL $QNRX $BOXD $EFOI $ASO, $SIGA $GFAI $REVB $FSRD $TOUR $CMRX, $CELZ, $FNHC $NBEV $COWN $RNW $OCFT $NISN $AAL $WISH $SOLO $APDN $BNGO $INO $VXRT $GCLT $CHNC $HIRU $VXIT $SSOF $GMPR $PASO $GMEV $SRMX $SANP $NNRX $FTEG $EEGI $CBDL $KYNC $WDLF $COWI $RMRK $FCGD $GWHP $GNBT $WLYYF $USEI $TGHI $NIOBF $BFCH $ZAAG $USMJ $JPEX $CZNI $MSPC $QNRX $LUNC.X $INPX $META $NVDA $MU $AMD $OXY $XOM $RIG $MRO $SWM $CVX $AMC $RBLX $DKNG $AAL $CCL $NCLH $CSX $PLTR $CLVS $MRNA$EVFM $LXRX $FCX $GOLD $KGC $HYMC $PGEN $GRAB $FFIE $DNA $NU $BLUE $UPS $KO $GM $MCD $GE $RTX $MMM $ADM $ACI $CNC $KMB $GLW $FISV $TRU $UBS $PHM $ECL $PII $ONB $CEQP $GPK $XRX $ARCC $IRDM $PCAR $MSCI $MCO $AAN $SSTK $FELE $PEBO $HUBB $WSO $AVNT $FFWM $PNR $ST $AWI $NXRT $CAC $CVLT
$ARKK $BLI $ONEM $SKLZ $PATH $HOOD $TDOC
Doesn't take much to make PPS move UP now. Shawts are worried. Capture Soldiers. --- * J The Legend !
$AMTD $HKD $FAZE $SYM $KPLT $ISEE $DARE $ENVB $UWMC $ANY $DVAX $EXPR $KPTI $CHS $AIKI $AEI $APRN $EVGO $PHUN $HYLN $ MVIS $GOEV $MNMD $ROOT $MKD $BTBT $MMAT $NAK $AUPH $NNDM $SDC $GSAT $STEM $RDBX $IDEX $WE $DBGI $BNGO $BKKT $BB $OCGN $CLOV $ATER
$AEX $ARKK $AAL $AMC $AMD $AAPL $AMZN $APRN $ATER
$BBBY $BABA $BBI $BWV $BMEA $BBIG $BEAT $CCL $CEI
$ERIC $RIDE $SPCE $SKLZ $CSCW $FSR $GRAB $WISH $CLF $DIDI $FUBO $OPEN $BRQS $CYN $CEI $YLRY $FAMI $NOK $LCID $VALE $MULN $BBIG $SNDL $RIVN $CFVI $DWAC
$DAL $DKNG $GME $GLD $GLE $HOOD $HYMC $ITP $ING $IGEX
$JBLU $LCID $LUV $MULN $META $MULN $NCLH $NDX $PVSP
$QQQ $RCL $RDBX $SAVE $STRN $STEM $SPY $SAVE $SPX $SOFI $SNOA $TWTR $TKAT $TSLA $UAL $VERU $XRTX $XCUR $CENN $AEI $LYFT $JWN $DKS $WEN $INTU $NERO $WEJO $TTOO $VYNE $SIOX $ALNA $ROKU $ARKK $COMP $BHLB $ADER $OCGN $ALZN $ADTX $PLTR, $RKT $SOFI $SNDL $AGRX $DPLS $ADN $RIGL $QNRX $BOXD $EFOI $ASO, $SIGA $GFAI $REVB $FSRD $TOUR $CMRX, $CELZ, $FNHC $NBEV $COWN $RNW $OCFT $NISN $AAL $WISH $SOLO $APDN $BNGO $INO $VXRT $GCLT $CHNC $HIRU $VXIT $SSOF $GMPR $PASO $GMEV $SRMX $SANP $NNRX $FTEG $EEGI $CBDL $KYNC $WDLF $COWI $RMRK $FCGD $GWHP $GNBT $WLYYF $USEI $TGHI $NIOBF $BFCH $ZAAG $USMJ $JPEX $CZNI $MSPC $QNRX $LUNC.X $INPX $META $NVDA $MU $AMD $OXY $XOM $RIG $MRO $SWM $CVX $AMC $RBLX $DKNG $AAL $CCL $NCLH $CSX $PLTR $CLVS $MRNA$EVFM $LXRX $FCX $GOLD $KGC $HYMC $PGEN $GRAB $FFIE $DNA $NU $BLUE $UPS $KO $GM $MCD $GE $RTX $MMM $ADM $ACI $CNC $KMB $GLW $FISV $TRU $UBS $PHM $ECL $PII $ONB $CEQP $GPK $XRX $ARCC $IRDM $PCAR $MSCI $MCO $AAN $SSTK $FELE $PEBO $HUBB $WSO $AVNT $FFWM $PNR $ST $AWI $NXRT $CAC $CVLT
>> XELA << I'm In. --- * J The Legend !
$AMTD $HKD $FAZE $SYM $KPLT $ISEE $DARE $ENVB $UWMC $ANY $DVAX $EXPR $KPTI $CHS $AIKI $AEI $APRN $EVGO $PHUN $HYLN $ MVIS $GOEV $MNMD $ROOT $MKD $BTBT $MMAT $NAK $AUPH $NNDM $SDC $GSAT $STEM $RDBX $IDEX $WE $DBGI $BNGO $BKKT $BB $OCGN $CLOV $ATER
$AEX $ARKK $AAL $AMC $AMD $AAPL $AMZN $APRN $ATER
$BBBY $BABA $BBI $BWV $BMEA $BBIG $BEAT $CCL $CEI
$ERIC $RIDE $SPCE $SKLZ $CSCW $FSR $GRAB $WISH $CLF $DIDI $FUBO $OPEN $BRQS $CYN $CEI $YLRY $FAMI $NOK $LCID $VALE $MULN $BBIG $SNDL $RIVN $CFVI $DWAC
$DAL $DKNG $GME $GLD $GLE $HOOD $HYMC $ITP $ING $IGEX
$JBLU $LCID $LUV $MULN $META $MULN $NCLH $NDX $PVSP
$QQQ $RCL $RDBX $SAVE $STRN $STEM $SPY $SAVE $SPX $SOFI $SNOA $TWTR $TKAT $TSLA $UAL $VERU $XRTX $XCUR $CENN $AEI $LYFT $JWN $DKS $WEN $INTU $NERO $WEJO $TTOO $VYNE $SIOX $ALNA $ROKU $ARKK $COMP $BHLB $ADER $OCGN $ALZN $ADTX $PLTR, $RKT $SOFI $SNDL $AGRX $DPLS $ADN $RIGL $QNRX $BOXD $EFOI $ASO, $SIGA $GFAI $REVB $FSRD $TOUR $CMRX, $CELZ, $FNHC $NBEV $COWN $RNW $OCFT $NISN $AAL $WISH $SOLO $APDN $BNGO $INO $VXRT $GCLT $CHNC $HIRU $VXIT $SSOF $GMPR $PASO $GMEV $SRMX $SANP $NNRX $FTEG $EEGI $CBDL $KYNC $WDLF $COWI $RMRK $FCGD $GWHP $GNBT $WLYYF $USEI $TGHI $NIOBF $BFCH $ZAAG $USMJ $JPEX $CZNI $MSPC $QNRX $LUNC.X $INPX $META $NVDA $MU $AMD $OXY $XOM $RIG $MRO $SWM $CVX $AMC $RBLX $DKNG $AAL $CCL $NCLH $CSX $PLTR $CLVS $MRNA$EVFM $LXRX $FCX $GOLD $KGC $HYMC $PGEN $GRAB $FFIE $DNA $NU $BLUE $UPS $KO $GM $MCD $GE $RTX $MMM $ADM $ACI $CNC $KMB $GLW $FISV $TRU $UBS $PHM $ECL $PII $ONB $CEQP $GPK $XRX $ARCC $IRDM $PCAR $MSCI $MCO $AAN $SSTK $FELE $PEBO $HUBB $WSO $AVNT $FFWM $PNR $ST $AWI $NXRT $CAC $CVLT
Jay Dilks
@DilksJay
I’ve sort of noticed some “Value” Managers that have been critics of $ARKK &
@CathieDWood
have been unusually quite as a reckoning has come to their Funds in the form of outflows & underperformance. They tried to seduce you w/ safety and all they have delivered is false promises
11:19 AM · Jul 24, 2022
What comes next for them is deflection and pointing to brief outperformance a year ago while trying to misdirect underperformance for the past 10-20 years. I’m not one to name names, but they know who they are. Investing is humbling enough without attacking other Managers.
At the time of someone else’s choosing, they’ve put together a compilation of Tweets over the last year of popular Twitter Personalities and Managers of what their top picks were at the time. Some of these picks have been quite awful in 2022. If they manage money, they’ve lost.
It's up $32 dollars Extended Hours. --- * J The Legend !
$MEGL $AMTD $HKD $FAZE $SYM $KPLT $ISEE $DARE $ENVB $UWMC $ANY $DVAX $EXPR $KPTI $CHS $AIKI $AEI $APRN $EVGO $PHUN $HYLN $ MVIS $GOEV $MNMD $ROOT $MKD $BTBT $MMAT $NAK $AUPH $NNDM $SDC $GSAT $STEM $RDBX $IDEX $WE $DBGI $BNGO $BKKT $BB $OCGN $CLOV $ATER
$AEX $ARKK $AAL $AMC $AMD $AAPL $AMZN $APRN $ATER
$BBBY $BABA $BBI $BWV $BMEA $BBIG $BEAT $CCL $CEI
$ERIC $RIDE $SPCE $SKLZ $CSCW $FSR $GRAB $WISH $CLF $DIDI $FUBO $OPEN $BRQS $CYN $CEI $YLRY $FAMI $NOK $LCID $VALE $MULN $BBIG $SNDL $RIVN $CFVI $DWAC
$DAL $DKNG $GME $GLD $GLE $HOOD $HYMC $ITP $ING $IGEX
$JBLU $LCID $LUV $MULN $META $MULN $NCLH $NDX $PVSP
$QQQ $RCL $RDBX $SAVE $STRN $STEM $SPY $SAVE $SPX $SOFI $SNOA $TWTR $TKAT $TSLA $UAL $VERU $XRTX $XCUR $CENN $AEI $LYFT $JWN $DKS $WEN $INTU $NERO $WEJO $TTOO $VYNE $SIOX $ALNA $ROKU $ARKK $COMP $BHLB $ADER $OCGN $ALZN $ADTX $PLTR, $RKT $SOFI $SNDL $AGRX $DPLS $ADN $RIGL $QNRX $BOXD $EFOI $ASO, $SIGA $GFAI $REVB $FSRD $TOUR $CMRX, $CELZ, $FNHC $NBEV $COWN $RNW $OCFT $NISN $AAL $WISH $SOLO $APDN $BNGO $INO $VXRT $GCLT $CHNC $HIRU $VXIT $SSOF $GMPR $PASO $GMEV $SRMX $SANP $NNRX $FTEG $EEGI $CBDL $KYNC $WDLF $COWI $RMRK $FCGD $GWHP $GNBT $WLYYF $USEI $TGHI $NIOBF $BFCH $ZAAG $USMJ $JPEX $CZNI $MSPC $QNRX $LUNC.X $INPX $META $NVDA $MU $AMD $OXY $XOM $RIG $MRO $SWM $CVX $AMC $RBLX $DKNG $AAL $CCL $NCLH $CSX $PLTR $CLVS $MRNA$EVFM $LXRX $FCX $GOLD $KGC $HYMC $PGEN $GRAB $FFIE $DNA $NU $BLUE $UPS $KO $GM $MCD $GE $RTX $MMM $ADM $ACI $CNC $KMB $GLW $FISV $TRU $UBS $PHM $ECL $PII $ONB $CEQP $GPK $XRX $ARCC $IRDM $PCAR $MSCI $MCO $AAN $SSTK $FELE $PEBO $HUBB $WSO $AVNT $FFWM $PNR $ST $AWI $NXRT $CAC $CVLT
$AMTD $HKD $FAZE $SYM $KPLT $ISEE $DARE $ENVB $UWMC $ANY $DVAX $EXPR $KPTI $CHS $AIKI $AEI $APRN $EVGO $PHUN $HYLN $ MVIS $GOEV $MNMD $ROOT $MKD $BTBT $MMAT $NAK $AUPH $NNDM $SDC $GSAT $STEM $RDBX $IDEX $WE $DBGI $BNGO $BKKT $BB $OCGN $CLOV $ATER
$AEX $ARKK $AAL $AMC $AMD $AAPL $AMZN $APRN $ATER
$BBBY $BABA $BBI $BWV $BMEA $BBIG $BEAT $CCL $CEI
$ERIC $RIDE $SPCE $SKLZ $CSCW $FSR $GRAB $WISH $CLF $DIDI $FUBO $OPEN $BRQS $CYN $CEI $YLRY $FAMI $NOK $LCID $VALE $MULN $BBIG $SNDL $RIVN $CFVI $DWAC
$DAL $DKNG $GME $GLD $GLE $HOOD $HYMC $ITP $ING $IGEX
$JBLU $LCID $LUV $MULN $META $MULN $NCLH $NDX $PVSP
$QQQ $RCL $RDBX $SAVE $STRN $STEM $SPY $SAVE $SPX $SOFI $SNOA $TWTR $TKAT $TSLA $UAL $VERU $XRTX $XCUR $CENN $AEI $LYFT $JWN $DKS $WEN $INTU $NERO $WEJO $TTOO $VYNE $SIOX $ALNA $ROKU $ARKK $COMP $BHLB $ADER $OCGN $ALZN $ADTX $PLTR, $RKT $SOFI $SNDL $AGRX $DPLS $ADN $RIGL $QNRX $BOXD $EFOI $ASO, $SIGA $GFAI $REVB $FSRD $TOUR $CMRX, $CELZ, $FNHC $NBEV $COWN $RNW $OCFT $NISN $AAL $WISH $SOLO $APDN $BNGO $INO $VXRT $GCLT $CHNC $HIRU $VXIT $SSOF $GMPR $PASO $GMEV $SRMX $SANP $NNRX $FTEG $EEGI $CBDL $KYNC $WDLF $COWI $RMRK $FCGD $GWHP $GNBT $WLYYF $USEI $TGHI $NIOBF $BFCH $ZAAG $USMJ $JPEX $CZNI $MSPC $QNRX $LUNC.X $INPX $META $NVDA $MU $AMD $OXY $XOM $RIG $MRO $SWM $CVX $AMC $RBLX $DKNG $AAL $CCL $NCLH $CSX $PLTR $CLVS $MRNA$EVFM $LXRX $FCX $GOLD $KGC $HYMC $PGEN $GRAB $FFIE $DNA $NU $BLUE $UPS $KO $GM $MCD $GE $RTX $MMM $ADM $ACI $CNC $KMB $GLW $FISV $TRU $UBS $PHM $ECL $PII $ONB $CEQP $GPK $XRX $ARCC $IRDM $PCAR $MSCI $MCO $AAN $SSTK $FELE $PEBO $HUBB $WSO $AVNT $FFWM $PNR $ST $AWI $NXRT $CAC $CVLT
Gps' Lead investigator, the Chair of MD Andersons Leukemia Dept, sees open label p3 trial data, and has requested Expanded Access for additional AML patients, - basically confirming Gps is doing what it has done in all previous trials, including the Moffitt Center P2, where Gps patients survived an average of 21 months compared to only 5.4 with the best available treatments.
Control Patients in the phase 3 are on the same one of 4 treatments used in the P2. There have been no new therapies, since.